| Authors: |
Hopkin G; Science, Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), Manchester, England, United Kingdom., Ayiku L; Science, Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), Manchester, England, United Kingdom., Branson R; Medicines and Healthcare Products Regulatory Agency (MHRA), London, England, United Kingdom., Coole H; Medicines and Healthcare Products Regulatory Agency (MHRA), London, England, United Kingdom., Edelmann F; Medicines and Healthcare Products Regulatory Agency (MHRA), London, England, United Kingdom., Hughes S; Science, Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), Manchester, England, United Kingdom. Electronic address: sophie.hughes@nice.org.uk., Powell J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Salmon M; Science, Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), Manchester, England, United Kingdom., Cooper S; Science, Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), Manchester, England, United Kingdom. |